Actelion receives Canada approval for Uptravi

ZURICH (Reuters) - Actelion Ltd , Europe's biggest biotech firm, said on Tuesday that Health Canada had granted a notice of compliance for Uptravi, a new pulmonary arterial hypertension medicine.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro